• RediHealth's October 28, 2026, analysis found divided views on patient support technology among more than 100 pharmaceutical patient support leaders surveyed.
• 52% viewed legacy solutions as too slow to innovate; 50% saw emerging vendors as driving the industry forward.
• Successful programs prioritize personalized patient engagement, faster therapy access and measurable outcomes rather than choosing partners solely by legacy or emerging status.
• For 2027 planning, the analysis urged teams to prioritize partners that accommodate patient preferences and compliance requirements without slowing innovation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RediHealth Inc. published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.